JENNIFER KEELEY: Open Payments
NPI 1932488046 · WEXFORD, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$44,493 in 137 payments from 13 companies in 2025. Trend: 2023 $8,143 · 2024 $32,146 · 2025 $44,493
Speaker / faculty: $19,001Consulting: $12,595Travel & lodging: $9,492Food & beverage: $3,405
| Company | Payments | Amount |
|---|---|---|
| Alnylam Pharmaceuticals Inc. | 37 | $16,748 |
| Johnson & Johnson Health Care Systems Inc. | 33 | $13,194 |
| E.R. Squibb & Sons, L.L.C. | 18 | $6,643 |
| Actelion Pharmaceuticals US, Inc. | 18 | $4,329 |
| BridgeBio Pharma, Inc. | 8 | $2,439 |
| United Therapeutics Corporation | 4 | $548 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $293 |
| AstraZeneca Pharmaceuticals LP | 2 | $85 |
| PFIZER INC. | 3 | $59 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $54 |
Products named: AMVUTTRA, OPSUMIT, CAMZYOS, UPTRAVI, Attruby, Adempas, ELIQUIS, WAINUA.
Industry payments across PA — which companies pay providers there.
